asa statement glp-1 Perioperative management of patients taking glucagon-like peptide-1 receptor agonists: a restrictive fasting regimen is not necessary. Comment on Br J Anaesth 2025; 135: 48–78 How should we approach patients

GLP-1 medications slow gastric emptying and reduce appetite, which typically lowers overall food intake

Mat naturally contains a wide range of polyphenols, methylxanthines, and chlorogenic acid, which together are responsible for its many health benefits.*

Not being able to merry make at all was depressing during the holidays (as a celiac who watches her diet, eating isn't that joyful to begin with)

It signals the brain to regulate appetite, promotes feelings of fullness making it essential for managing weight and overall metabolic health.* HOW TO TAKE: Take 4 capsules a day, preferably 15-30 minutes before meals

Factors such as side effects, high out-of-pocket costs, injection fatigue and stigma around obesity treatment drive troves of patients some studies estimate roughly half or more to stop GLP-1s within a year and risk regaining the weight they lost

The two interventions were: study 1, single dose of 10 g exenatide administered subcutaneously (s.c.)